End-of-life care accounts for a significant proportion of all health spending. Extensive efforts have been made to minimize that spending, which is often futile. A Research Letter in JAMA Internal Medicine analyzes recent trends in Medicare spending in regard to end-of-life care. (JAMA Int. Med. Art.) The researchers used Medicare fee-for-service data from 2004 to 2014 and looked at total average annual spending for all beneficiaries and for beneficiaries who had chronic conditions and died, comparing spending for those who continued to live and those who died. Spending in the two years prior to death was considered end-of-life spending; that seems like a long period. Over 4% of Medicare beneficiaries die each year. Overall per capita Medicare FFS expenditures per beneficiary per year increased between 2004 and 2009 from $9119 to $10,458; and decreased from 2009 to 2014 to $9589; which may reflect the influx of younger baby-boomers. Changes in practice intensity (the number of services for an episode) increased up to 2009, but then decreased. Most of the decrease, 55%, was attributable to decedents, even though they were only a little over 4% of all beneficiaries. The changes in spending occurred among inpatient, home health and physician services. The results suggest that in fact there have been significant results from efforts to control costs and utilization near end-of-life, which is good news for Medicare, which bears most of those costs. It would be interesting to see a comparison with Medicare Advantage, where there is even more incentive to manage spending carefully, and to ascertain if there are some spillover effects, especially among doctors with large MA patient pools.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Now here is a tale from the glory days of epidemic investing, as the Feds pumped trillions into the economy and a lot of it went to investing, some to...
January 10, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace